Sleep-Disordered Breathing and Coronary Artery Disease

Canadian Journal of Cardiology

Volumn 31, Issue 7, 2015, Pages 909-917

  Arzt, Michael ^a   Hetzenecker, Andrea ^a   Steiner, Stephan ^b   Buchner, Stefan ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b St Vincenz KH Auf dem Schafsberg   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; REACTIVE OXYGEN METABOLITE;

APNEA; ARTERIAL WALL THICKNESS; ARTERIOSCLEROSIS; BLOOD CLOTTING; CENTRAL SLEEP APNEA SYNDROME; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY HEMODYNAMICS; CORONARY RISK; ENDOTHELIAL DYSFUNCTION; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE REMODELING; HEART WORK; HUMAN; INTERMITTENT HYPOXIA; OXIDATIVE STRESS; OXYGEN CONSUMPTION; OXYGEN SUPPLY; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; POSITIVE END EXPIRATORY PRESSURE; REVIEW; SLEEP AROUSAL DISORDER; SLEEP DISORDERED BREATHING; THROMBOCYTE AGGREGATION; COMPLICATION; HEALTH; MORBIDITY; RISK FACTOR; SLEEP APNEA SYNDROMES; TRENDS;

CORONARY ARTERY DISEASE; GLOBAL HEALTH; HUMANS; MORBIDITY; RISK FACTORS; SLEEP APNEA SYNDROMES;

EID: 84937576303     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2015.03.032     Document Type: Review

References (84)

1. Mozaffarian D., Benjamin E.J., Go A.S., et al. Heart disease and stroke statistics-2015 update: a report from the American Heart Association. Circulation 2015, 131:e29-322.
2. Lloyd-Jones D.M., Larson M.G., Beiser A., Levy D. Lifetime risk of developing coronary heart disease. Lancet 1999, 353:89-92.
3. Kasai T., Floras J.S., Bradley T.D. Sleep apnea and cardiovascular disease: a bidirectional relationship. Circulation 2012, 126:1495-1510.
4. Gottlieb D.J., Yenokyan G., Newman A.B., et al. Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study. Circulation 2010, 122:352-360.
5. Steiner S., Arzt M. Coronary artery disease and sleep-disordered breathing. Somnologie 2014, 18:189-193. [in German].
6. Kendzerska T., Mollayeva T., Gershon A.S., et al. Untreated obstructive sleep apnea and the risk for serious long-term adverse outcomes: a systematic review. Sleep Med Rev 2014, 18:49-59.
7. Buchner S., Greimel T., Hetzenecker A., et al. Natural course of sleep-disordered breathing after acute myocardial infarction. Eur Respir J 2012, 40:1173-1179.
8. Tkacova R., Niroumand M., Lorenzi-Filho G., Bradley T.D. Overnight shift from obstructive to central apneas in patients with heart failure: role of PCO2 and circulatory delay. Circulation 2001, 103:238-243.
9. Tkacova R., Rankin F., Fitzgerald F.S., Floras J.S., Bradley T.D. Effects of continuous positive airway pressure on obstructive sleep apnea and left ventricular afterload in patients with heart failure. Circulation 1998, 98:2269-2275.
10. Somers V.K., Dyken M.E., Clary M.P., Abboud F.M. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995, 96:1897-1904.
11. Arzt M., Harth M., Luchner A., et al. Enhanced ventilatory response to exercise in patients with chronic heart failure and central sleep apnea. Circulation 2003, 107:1998-2003.
12. Leung, Richard S.T., Floras J.S., et al. Influence of Cheyne-Stokes respiration on cardiovascular oscillations in heart failure. Am J Respir Crit Care Med 2003, 167:1534-1539.
13. Lee W., Nagubadi S., Kryger M.H., Mokhlesi B. Epidemiology of obstructive sleep apnea: a population-based perspective. Expert Rev Respir Med 2008, 2:349-364.
14. Andreas S. Nocturnal insights in chronic heart failure. Eur Heart J 1999, 20:1140-1141.
15. Mooe T., Olofsson B.O., Stegmayr B., Eriksson P. Ischemic stroke. Impact of a recent myocardial infarction. Stroke 1999, 30:997-1001.
16. Peker Y., Kraiczi H., Hedner J., et al. An independent association between obstructive sleep apnoea and coronary artery disease. Eur Respir J 1999, 14:179-184.
17. Sin D.D., Fitzgerald F., Parker J.D., et al. Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 1999, 160:1101-1106.
18. Carlson J.T., Rångemark C., Hedner J.A. Attenuated endothelium-dependent vascular relaxation in patients with sleep apnoea. J Hypertens 1996, 14:577-584.
19. Kadohira T., Kobayashi Y., Iwata Y., Kitahara H., Komuro I. Coronary artery endothelial dysfunction associated with sleep apnea. Angiology 2011, 62:397-400.
20. Budweiser S., Enderlein S., Jörres R.A., et al. Sleep apnea is an independent correlate of erectile and sexual dysfunction. J Sex Med 2009, 6:3147-3157.
21. Szymanski F.M., Filipiak K.J., Hrynkiewicz-Szymanska A., et al. The high risk of obstructive sleep apnea-an independent risk factor of erectile dysfunction in ST-segment elevation myocardial infarction patients. J Sex Med 2011, 8:1434-1438.
22. Lavie L. Oxidative stress in obstructive sleep apnea and intermittent hypoxia - revisited - the bad, ugly and good: implications to the heart and brain. Sleep Med Rev 2015, 20C:27-45.
23. Jelic S., Padeletti M., Kawut S.M., et al. Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea. Circulation 2008, 117:2270-2278.
24. Jelic S., Lederer D.J., Adams T., et al. Vascular inflammation in obesity and sleep apnea. Circulation 2010, 121:1014-1021.
25. Schulz R., Mahmoudi S., Hattar K., et al. Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 2000, 162:566-570.
26. Dyugovskaya L., Lavie P., Lavie L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 2002, 165:934-939.
27. Barceló A., Miralles C., Barbé F., et al. Abnormal lipid peroxidation in patients with sleep apnoea. Eur Respir J 2000, 16:644-647.
28. Lavie L., Vishnevsky A., Lavie P. Evidence for lipid peroxidation in obstructive sleep apnea. Sleep 2004, 27:123-128.
29. Ip M.S., Tse H., Lam B., Tsang K.W., Lam W. Endothelial function in obstructive sleep apnea and response to treatment. Am J Respir Crit Care Med 2004, 169:348-353.
30. Ohike Y., Kozaki K., Iijima K., et al. Amelioration of vascular endothelial dysfunction in obstructive sleep apnea syndrome by nasal continuous positive airway pressure-possible involvement of nitric oxide and asymmetric NG, NG-dimethylarginine. Circ J 2005, 69:221-226.
31. Grebe M., Eisele H.J., Weissmann N., et al. Antioxidant vitamin C improves endothelial function in obstructive sleep apnea. Am J Respir Crit Care Med 2006, 173:897-901.
32. El Solh A.A., Saliba R., Bosinski T., et al. Allopurinol improves endothelial function in sleep apnoea: a randomised controlled study. Eur Respir J 2006, 27:997-1002.
33. Schulz R., Schmidt D., Blum A., et al. Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy. Thorax 2000, 55:1046-1051.
34. Shamsuzzaman Abu SM., Winnicki M., et al. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 2002, 105:2462-2464.
35. Larkin E.K., Rosen C.L., Kirchner H.L., et al. Variation of C-reactive protein levels in adolescents: association with sleep-disordered breathing and sleep duration. Circulation 2005, 111:1978-1984.
36. Punjabi N.M., Beamer B.A. C-reactive protein is associated with sleep disordered breathing independent of adiposity. Sleep 2007, 30:29-34.
37. Guilleminault C., Kirisoglu C., Ohayon M.M. C-reactive protein and sleep-disordered breathing. Sleep 2004, 27:1507-1511.
38. Meier-Ewert H.K., Ridker P.M., Rifai N., et al. Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol 2004, 43:678-683.
39. Minoguchi K., Yokoe T., Tazaki T., et al. Increased carotid intima-media thickness and serum inflammatory markers in obstructive sleep apnea. Am J Respir Crit Care Med 2005, 172:625-630.
40. Ryan S., Taylor C.T., McNicholas W.T. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 2005, 112:2660-2667.
41. Yokoe T., Minoguchi K., Matsuo H., et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 2003, 107:1129-1134.
42. Monneret D., Pepin J., Godin-Ribuot D., et al. Association of urinary 15-F2t-isoprostane level with oxygen desaturation and carotid intima-media thickness in nonobese sleep apnea patients. Free Rad Biol Med 2010, 48:619-625.
43. Pirillo A., Norata G.D., Catapano A.L. LOX-1, OxLDL, and atherosclerosis. Mediat Inflamm 2013, 2013:152786.
44. Drager L.F., Bortolotto L.A., Lorenzi M.C., et al. Early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 2005, 172:613-618.
45. Schulz R., Seeger W., Fegbeutel C., et al. Changes in extracranial arteries in obstructive sleep apnoea. Eur Respir J 2005, 25:69-74.
46. Hui D.S., Shang Q., Ko F.W., et al. A prospective cohort study of the long-term effects of CPAP on carotid artery intima-media thickness in obstructive sleep apnea syndrome. Respir Res 2012, 13:22.
47. Sharma S., Gebregziabher M., Parker A.T., et al. Independent association between obstructive sleep apnea and noncalcified coronary plaque demonstrated by noninvasive coronary computed tomography angiography. Clin Cardiol 2012, 35:641-645.
48. Weinreich G., Wessendorf T.E., Erdmann T., et al. Association of obstructive sleep apnoea with subclinical coronary atherosclerosis. Atherosclerosis 2013, 231:191-197.
49. Kent B.D., Garvey J.F., Ryan S., et al. Severity of obstructive sleep apnoea predicts coronary artery plaque burden: a coronary computed tomographic angiography study. Eur Respir J 2013, 42:1263-1270.
50. Marin J.M., Carrizo S.J., Vicente E., Agusti A.G. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005, 365:1046-1053.
51. Hetzenecker A., Buchner S., Greimel T., et al. Cardiac workload in patients with sleep-disordered breathing early after acute myocardial infarction. Chest 2013, 143:1294-1301.
52. Davies C.W., Crosby J.H., Mullins R.L., et al. Case-control study of 24 hour ambulatory blood pressure in patients with obstructive sleep apnoea and normal matched control subjects. Thorax 2000, 55:736-740.
53. Hamilton G.S., Meredith I.T., Walker A.M., Solin P. Obstructive sleep apnea leads to transient uncoupling of coronary blood flow and myocardial work in humans. Sleep 2009, 32:263-270.
54. Hamilton G.S., Solin P., Walker A. Coronary blood flow becomes uncoupled from myocardial work during obstructive sleep apnea in the presence of endothelial dysfunction. Sleep 2008, 31:809-816.
55. Arbab-Zadeh A., Levine B.D., Trost J.C., et al. The effect of acute hypoxemia on coronary arterial dimensions in patients with coronary artery disease. Cardiology 2009, 113:149-154.
56. Hanly P., Sasson Z., Zuberi N., Lunn K. ST-segment depression during sleep in obstructive sleep apnea. Am J Cardiol 1993, 71:1341-1345.
57. Peled N., Abinader E.G., Pillar G., Sharif D., Lavie P. Nocturnal ischemic events in patients with obstructive sleep apnea syndrome and ischemic heart disease: effects of continuous positive air pressure treatment. J Am Coll Cardiol 1999, 34:1744-1749.
58. Schäfer H., Koehler U., Ploch T., Peter J.H. Sleep-related myocardial ischemia and sleep structure in patients with obstructive sleep apnea and coronary heart disease. Chest 1997, 111:387-393.
59. Einvik G., Røsjø H., Randby A., et al. Severity of obstructive sleep apnea is associated with cardiac troponin I concentrations in a community-based sample: data from the Akershus Sleep Apnea Project. Sleep 2014, 37:1111-1116. 1116A-B.
60. Bokinsky G., Miller M., Ault K., Husband P., Mitchell J. Spontaneous platelet activation and aggregation during obstructive sleep apnea and its response to therapy with nasal continuous positive airway pressure. A preliminary investigation. Chest 1995, 108:625-630.
61. Rahangdale S., Yeh S.Y., Novack V., et al. The influence of intermittent hypoxemia on platelet activation in obese patients with obstructive sleep apnea. J Clin Sleep Med 2011, 7:172-178.
62. Sanner B.M., Konermann M., Tepel M., et al. Platelet function in patients with obstructive sleep apnoea syndrome. Eur Respir J 2000, 16:648-652.
63. Hui D.S., Ko F.W., Fok J.P., et al. The effects of nasal continuous positive airway pressure on platelet activation in obstructive sleep apnea syndrome. Chest 2004, 125:1768-1775.
64. Wessendorf T.E., Thilmann A.F., Wang Y.M., et al. Fibrinogen levels and obstructive sleep apnea in ischemic stroke. Am J Respir Crit Care Med 2000, 162:2039-2042.
65. Mehra R., Xu F., Babineau D.C., et al. Sleep-disordered breathing and prothrombotic biomarkers: cross-sectional results of the Cleveland Family Study. Am J Respir Crit Care Med 2010, 182:826-833.
66. von Känel R., Loredo J.S., Ancoli-Israel S., Dimsdale J.E. Association between sleep apnea severity and blood coagulability: treatment effects of nasal continuous positive airway pressure. Sleep Breath 2006, 10:139-146.
67. Chin K., Ohi M., Kita H., et al. Effects of NCPAP therapy on fibrinogen levels in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 1996, 153:1972-1976.
68. De Torres-Alba F., Gemma D., Armada-Romero E., et al. Obstructive sleep apnea and coronary artery disease: from pathophysiology to clinical implications. Pulmon Med 2013, 2013:768064.
69. Shah N., Redline S., Yaggi H.K., et al. Obstructive sleep apnea and acute myocardial infarction severity: ischemic preconditioning?. Sleep Breath 2013, 17:819-826.
70. Lavie L., Lavie P. Ischemic preconditioning as a possible explanation for the age decline relative mortality in sleep apnea. Med Hypotheses 2006, 66:1069-1073.
71. Shah N, Kizer JR, Mohsenin V. Obstructive sleep apnea in the acute myocardial infarction setting - should I treat my patient? J Sleep Disord Treat Care 2013;2:1.
72. Steiner S., Schueller P.O., Schulze V., Strauer B.E. Occurrence of coronary collateral vessels in patients with sleep apnea and total coronary occlusion. Chest 2010, 137:516-520.
73. Berger S., Aronson D., Lavie P., Lavie L. Endothelial progenitor cells in acute myocardial infarction and sleep-disordered breathing. Am J Respir Crit Care Med 2013, 187:90-98.
74. Barbé F., Sánchez-de-la-Torre A., Abad J., et al. Effect of obstructive sleep apnoea on severity and short-term prognosis of acute coronary syndrome. Eur Respir J 2015, 45:419-427.
75. Buchner S., Satzl A., Debl K., et al. Impact of sleep-disordered breathing on myocardial salvage and infarct size in patients with acute myocardial infarction. Eur Heart J 2014, 35:192-199.
76. Nakashima H., Katayama T., Takagi C., et al. Obstructive sleep apnoea inhibits the recovery of left ventricular function in patients with acute myocardial infarction. Eur Heart J 2006, 27:2317-2322.
77. Aronson D., Nakhleh M., Zeidan-Shwiri T., et al. Clinical implications of sleep disordered breathing in acute myocardial infarction. PLoS One 2014, 9:e88878.
78. Sert Kuniyoshi F.H., Singh P., Gami A.S., et al. Patients with obstructive sleep apnea exhibit impaired endothelial function after myocardial infarction. Chest 2011, 140:62-67.
79. Nakashima H., Muto S., Amenomori K., et al. Impact of obstructive sleep apnea on myocardial tissue perfusion in patients with ST-segment elevation myocardial infarction. Circ J 2011, 75:890-896.
80. Buchner S., Eglseer M., Debl K., et al. Sleep disordered breathing and enlargement of the right heart after myocardial infarction. Eur Respir J 2015, 45:680-690.
81. Lee C., Khoo S., Chan M.Y., et al. Severe obstructive sleep apnea and outcomes following myocardial infarction. J Clin Sleep Med 2011, 7:616-621.
82. Garcia-Rio F., Alonso-Fernández A., Armada E., et al. CPAP effect on recurrent episodes in patients with sleep apnea and myocardial infarction. Int J Cardiol 2013, 168:1328-1335.
83. Hetzenecker A., Arzt M. KHK & Schlafbezogene Atmungsstörungen. Schlaf 2014, 11-15.
84. Alonso-Fernández A., García-Río F., Arias M.A., et al. Effects of CPAP on oxidative stress and nitrate efficiency in sleep apnoea: a randomised trial. Thorax 2009, 64:581-586.